Arca
Skip to content
Tools
Tools

Bilirubin

Small molecule in Homo sapiens that 1 drug acts on.

  • Drugs that act on it: 1
  • Approved: 1
  • In phases 1 to 3: 0
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Protein or peptide 1

Approved1

  • Albumin human

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        Albumin humanApprovedGEProtein or peptideSequestering agentBilirubin sequestering agent114

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Phase I Trial of Subcutaneous VDJ010 In Healthy Subjects and Patients With Ulcerative ColitisAlbumin humanPhase 1RecruitingBeijing VDJBio Co., LTD.Nov 12, 2026
        Low Dose Versus Standard Dose AlbuminAlbumin humanPhase 4Enrolling by invitationBangladesh Medical UniversityNov 5, 2026
        A Study to Learn the Safety and Efficacy of HLX37 in Combination With Chemotherapy for First-line Treatment in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerAlbumin humanPhase 2 / Phase 3Not yet recruitingShanghai Henlius BiotechOct 8, 2026
        Effect of Albumin Therapy in Mechanically Ventilated Patients With Sepsis-Associated ARDSAlbumin human—Not yet recruitingThe Second Affiliated Hospital of Hainan Medical UniversityOct 5, 2026
        A Phase I Clinical Study on the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Characteristics of GLR1075 Injection in Healthy Trial Participants and Cirrhotic Trial Participants With Ascites and HypoalbuminemiaAlbumin humanPhase 1Not yet recruitingGan & Lee Pharmaceuticals.Oct 1, 2026
        Human Albumin Combined With Plasma Exchange for Frailty InterventionAlbumin humanNot applicableNot yet recruitingInstitute of Hematology & Blood Diseases Hospital, ChinaSep 23, 2026
        Intranasal Stem Cells to Treat Perinatal Brain Injury to Combat Cerebral PalsyAlbumin humanPhase 2 / Phase 3Not yet recruitingUMC UtrechtSep 21, 2026
        Human Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic NephropathyAlbumin humanPhase 1RecruitingTongji HospitalSep 16, 2026

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364174, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.